First implantation of heart and bone marrow transplantation

China first successfully performed a heart and bone marrow transplant surgery for a 37-year-old patient.

Illustration. (Internet source)

Scientists from An Trinh Hospital, Beijing, China, said the purpose of successful surgery after heart transplant, continued to perform bone marrow stem cell transplantation to help patients lower their dosage. Anti-rejection drug.

Usually a patient after a heart transplant needs to use anti-rejection medication. On average, a year, patients have to pay huge drug costs. However, if after heart transplant, continue to perform bone marrow transplant, the patient can minimize the use of the drug, even without the use of anti-rejection drugs.

Currently, the patient only uses 1/3 of the dose of anti-rejection medication compared to the amount of medicine needed to be used in conventional heart transplant surgery. Moreover, the transplanted heart does not have a pronounced anti-immune response.

According to scientists, after a while the patient will be able to not need to use the drug and can fully function as a normal person.